Attend Our Live Webinar!
In this webinar, industry expert Leora Horn will share how Astrazeneca is using multimodal data to aid in the design of all Phase 3 studies across the oncology portfolio, which resulted in an overall increase in PTS by 5 percentage points per study. She will also discuss the use of real-world data to select the right patient populations to enroll in studies and inform study design and stratification factors.
Register for this webinar to learn more.
Featured Speakers
![](https://go.tempus.com/rs/833-QRC-346/images/Tempus_Huerga-Iker.jpeg)
Iker Huerga
SVP, Life Sciences Strategy
Tempus
Tempus
![](https://go.tempus.com/rs/833-QRC-346/images/Tempus_logo%28black%29.png)
![](https://go.tempus.com/rs/833-QRC-346/images/AstraZeneca_Leora-Horn%20%281%29.png)
Leora Horn, MD
Global Clinical Head for Lung Cancer & Lung Cancer Strategy
AstraZeneca
AstraZeneca
![](https://go.tempus.com/rs/833-QRC-346/images/Astrazeneca_Black.png)